Company Description

Flare Therapeutics is a clinical-stage biotechnology company exclusively focused on drugging transcription factors to fully unlock the therapeutic potential of this previously elusive target class. The company's development portfolio targeting transcription factors involved in oncology leverages Flare Therapeutics' integrated discovery platform of capabilities that identifies novel validated ligands to the undrugged proteome.